Log in to save to my catalogue

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5758901

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Fibrolamellar carcinoma has a distinctive morphology and immunophenotype, including cytokeratin 7 and CD68 co-expression. Despite the distinct findings, accurate diagnosis of fibrolamellar carcinoma continues to be a challenge. Recently, fibrolamellar carcinomas were found to harbor a characteristic somatic gene fusion,
DNAJB1–PRKACA
. A brea...

Alternative Titles

Full title

Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5758901

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5758901

Other Identifiers

ISSN

0893-3952

E-ISSN

1530-0285

DOI

10.1038/modpathol.2017.103

How to access this item